Literature DB >> 8468529

Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.

D L Brasaemle1, K Cornely-Moss, A Bensadoun.   

Abstract

The consequences of hepatic lipase treatment of chylomicron remnants were studied. Rats were fed corn oil to induce production and secretion of chylomicrons and were then injected with polyclonal antiserum raised against hepatic lipase to specifically and quantitatively inhibit hepatic lipase activity in vivo. A fraction enriched in chylomicron remnants was isolated from rat plasma by a brief centrifugation step that preferentially isolates triglyceride-rich apolipoprotein (apo) B-48-containing lipoproteins. The chylomicron remnants were then treated with hepatic lipase in vitro, or incubated under identical conditions in the absence of enzyme (control incubations). Hepatic lipase-treated and control chylomicron remnants were isolated by a second brief centrifugation step using discontinuous salt gradients. Control lipoproteins were collected from one discrete band at d < 1.02 g/ml. Hepatic lipase-treated chylomicron remnants formed two discrete bands and were collected at two densities: d < 1.02 g/ml and 1.02 < d < 1.04 g/ml. The buoyant (d < 1.02 g/ml) subfraction of hepatic lipase-treated chylomicron remnants was depleted of 62% of the total phospholipid when compared to control d < 1.02 g/ml lipoproteins. The dense (1.02 < d < 1.04 g/ml) subfraction of hepatic lipase-treated chylomicron remnants was depleted of 65% of particle phospholipid content and 90% of particle triglyceride content when compared to control d < 1.02 g/ml lipoproteins. The dense (1.02 < d < 1.04 g/ml) subfraction of hepatic lipase-treated chylomicron remnants showed 5- to 7-fold greater immunoreactivity of apoE when compared to control lipoproteins in competitive displacement immunoassays. These data suggest that extensive hydrolysis of chylomicron remnant phospholipid and triglyceride leads to the formation of a dense remnant particle that contains highly exposed apoE. This increased exposure of apoE may be the key to the previously observed increased degradation of chylomicron remnants treated with hepatic lipase because more exposed apoE may bind better to cell surface lipoprotein receptors. Furthermore, the data imply that hepatic lipase cleaves chylomicron remnant phospholipid and triglyceride in a sequential fashion; hydrolytic intermediates depleted only of phospholipid precede the formation of a smaller dense remnant particle depleted of phospholipid and triglyceride.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468529

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase.

Authors:  N Bergeron; L Kotite; M Verges; P Blanche; R L Hamilton; R M Krauss; A Bensadoun; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.

Authors:  M F Linton; A H Hasty; V R Babaev; S Fazio
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

3.  Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

Authors:  J D Medh; G L Fry; S L Bowen; S Ruben; H Wong; D A Chappell
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

4.  Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.

Authors:  J Herz; S Q Qiu; A Oesterle; H V DeSilva; S Shafi; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

5.  Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes.

Authors:  P Diard; M I Malewiak; D Lagrange; S Griglio
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia.

Authors:  Wieneke Dijk; Mathilde Di Filippo; Cédric Le May; Philippe Moulin; Bertrand Cariou; Sander Kooijman; Robin van Eenige; Antoine Rimbert; Amandine Caillaud; Aurélie Thedrez; Lucie Arnaud; Amanda Pronk; Damien Garçon; Thibaud Sotin; Pierre Lindenbaum; Enrique Ozcariz Garcia; Jean-Paul Pais de Barros; Laurence Duvillard; Karim Si-Tayeb; Nuria Amigo; Jean-Yves Le Questel; Patrick C N Rensen
Journal:  Circulation       Date:  2022-07-28       Impact factor: 39.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.